[1]孟晓红,徐海伟,孙成,等.假性视网膜色素变性临床特征研究[J].第三军医大学学报,2019,41(20):1969-1975.
 MENG Xiaohong,XU Haiwei,SUN Cheng,et al.Clinical characteristics of pseudoretinitis pigmentosa: analysis of 26 cases[J].J Third Mil Med Univ,2019,41(20):1969-1975.
点击复制

假性视网膜色素变性临床特征研究(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
41卷
期数:
2019年第20期
页码:
1969-1975
栏目:
临床医学
出版日期:
2019-10-30

文章信息/Info

Title:
Clinical characteristics of pseudoretinitis pigmentosa: analysis of 26 cases
作者:
孟晓红徐海伟孙成王刚李世迎
陆军军医大学(第三军医大学)第一附属医院眼科
Author(s):
MENG Xiaohong XU Haiwei SUN Cheng WANG Gang LI Shiying

Department of Ophthalmology, First Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, China

关键词:
视网膜变性假性视网膜色素变性病因临床表现
Keywords:
retinal degeneration pseudoretinitis pigmentosa etiology clinical manifestations  
分类号:
R444;R447;R774.1
文献标志码:
A
摘要:

目的 探讨假性视网膜色素变性(pseudo retinitis pigmentosa,PRP)患者的临床特征。方法 回顾性分析2014年12月至2018年10月就诊于陆军军医大学第一附属医院眼科的PRP患者26例,并选择年龄匹配的视网膜色素变性(retinitis pigmentosa,RP)患者30例作为对照,分析PRP病因、病程、最佳矫正视力(best corrected visual acuity,BCVA)、眼底特征和全视野闪光视网膜电图(full field flash electroretinogram,FERG)改变。结果26例PRP患者年龄26~56岁,其中男性12例,女性14例,单眼发病22例22眼(84.6%),双眼发病4例8眼(15.4%),病程6个月至5年,最佳矫正视力无光感~1.2,无夜盲主诉。RP患者30例,男性13例,女性17例,平均病程27年。PRP原发病因:葡萄膜炎(40.0%),视网膜脱离(36.7%),眼外伤(16.7%),其他(6.6%)。病程、BCVA RP和PRP患者相比,差异有统计学意义(P<0.05)。26例PRP患者眼底主要表现为双眼不对称性,视网膜色泽和色素分布以及视盘颜色改变与RP有别。PRP患者FERG显示双眼各波形幅值同步降低、双眼不对称,患眼的眼底改变与FERG幅值降低程度不一致。结论 PRP病因多样,病程短、不伴夜盲,其眼底改变、FERG是PRP与RP鉴别诊断的主要指标。

Abstract:

Objective To analyze the clinical features of patients with pseudoretinitis pigmentosa (PRP). MethodsWe performed a retrospective case analysis among 26 patients with PRP admitted in our department between December, 2014 and October, 2018, with 30 age-matched patients with RP as the controls. The etiology, disease course, best corrected visual acuity (BCVA), fundus and full-field flash electroretinogram (FERG) changes were compared between the patients with RP and those with PRP.  ResultsOf the 26 patients with PRP (including 12 male and 14 female patients aged from 26 to 56 years), 22 (84.6%) had unilateral PRP and 4 (15.4%) had bilateral PRP, and the disease course ranged from 6 months to 5 years. The BCVA of these patients ranged from no light perception to 1.2, and none of the patients complained of night blindness. The 30 control patients with RP included 13 male and 17 female patients with a mean disease duration of 27 years. The primary causes of PRP included uveitis (40.0%), retinal detachment (36.7%), ocular trauma (16.7%), and other factors (6.6%). The patients with RP and PRP had significantly different disease durations and BCVA (P<0.05). The patients with PRP typically manifested a bilateral asymmetry of the fundus, with obvious differences in retinal color, pigment distribution and visual disc color change from patients with RP. FERG of the patients with PRP revealed synchronously decreased amplitudes of the waveforms in the bilateral eyes with obvious eye asymmetry, and the reduction of FERG amplitude was not consistent with the changes in the fundus of the affected eyes. ConclusionThe causes of PRP are diverse, and the disease course is often short without night blindness. The changes in the fundus and FERG are the main indicators for differential diagnosis between PRP and RP.

参考文献/References:

[1]HAFLER B P. Clinical progress in inherited retinal degenerations:  gene therapy clinical trials and advances in genetic sequencing[J]. Retina (Philadelphia, Pa), 2017, 37(3):  417-423. DOI:  10.1097/IAE.0000000000001341.
[2]GUPTA P R, HUCKFELDT R M. Gene therapy for inherited retinal degenerations:  initial successes and future challenges[J]. J Neural Eng, 2017, 14(5):  051002. DOI:  10.1088/1741-2552/aa7a27.
[3]VERBAKEL S K, VAN HUET R A C, BOON C J F, et al. Non-syndromic retinitis pigmentosa[J]. Prog Retin Eye Res, 2018, 66:  157-186. DOI:  10.1016/j.preteyeres.2018.03.005.
[4]ZOBOR D, ZRENNER E. Retinitis pigmentosa - a review. Pathogenesis, guidelines for diagnostics and perspectives[J]. Ophthalmologe, 2012, 109(5):  501-514;quiz 515. DOI: 10.1007/s00347-012-2555-6.
[5]RIVOLTA C, SHARON D, DEANGELIS M M, et al. Retinitis pigmentosa and allied diseases:  numerous diseases, genes, and inheritance patterns[J]. Hum Mol Genet, 2002, 11(10):  1219-1227. DOI:  10.1093/hmg/11.10.1219.
[6]SEN P, BHARGAVA A, GEORGE R, et al. Prevalence of retinitis pigmentosa in South Indian population aged above 40 years[J]. Ophthalmic Epidemiol, 2008, 15(4):  279-281. DOI: 10.1080/09286580802105814.
[7]FERRARI S, DI IORIO E, BARBARO V, et al. Retinitis pigmentosa:  genes and disease mechanisms[J]. Curr Genomics,2011,12(4): 238-249. DOI: 10.2174/1389202117 95860107.
[8]SALES M J, SAADI R, ROYER G, et al. Pseudoretinitis pigmentosa caused by congenital rubella (apropos of a case)[J]. Bull Soc Ophtalmol Fr, 1989, 89(1):  185-187.
[9]BENSON M D, MACDONALD I M. Bilateral uveitis and Usher syndrome:  a case report[J]. J Med Case Rep, 2015, 9:  60. DOI:  10.1186/s13256-015-0534-7.
[10]CARBONI G, FORMA G, BOND A D, et al. Bilateral paraneoplastic optic neuropathy and unilateral retinal compromise in association with prostate cancer:  a differential diagnostic challenge in a patient with unexplained visual loss[J]. Doc Ophthalmol, 2012, 125(1):  63-70. DOI: 10.1007/s10633-012-9327-0.
[11]TEMKAR S, MUKHIJA R, VENKATESH P, et al. Pseudo retinitis pigmentosa in a case of missed intraocular foreign body[J]. BMJ Case Rep, 2017, 2017:  bcr-2017-220385. DOI:  10.1136/bcr-2017-220385.
[12]VELA J I, MARCANTONIO I, DAZ-CASCAJOSA J, et al. Progression of retinal pigmentation mimicking unilateral retinitis pigmentosa after bilateral pars planitis:  a case report[J]. BMC Ophthalmol, 2018, 18(1):  242. DOI:  10.1186/s12886-018-0814-2.
[13]WILLERMAIN F, GREINER K, FORRESTER J V. Atypical end-stage birdshot retinochoroidopathy[J]. Ocul Immunol Inflamm, 2003, 11(4):  305-307.
[14]SEVGI D D, DAVOUDI S, COMANDER J, et al. Retinal pigmentary changes in chronic uveitis mimicking retinitis pigmentosa[J]. Albrecht Von Graefes Arch Fur Klinische Und Exp Ophthalmol, 2017, 255(9):  1801-1810. DOI: 10.1007/s00417-017-3689-7.
[15]CHEBIL A, EL MATRI L. Retinitis pigmentosa associated with Coats-like fundus[J]. J Fr Ophtalmol, 2016, 39(2):  235-236. DOI: 10.1016/j.jfo.2015.09.007.
[16]TURAN-VURAL E, TORUN-ACAR B, TKENMEZ N, et al. Usher syndrome associated with Fuchs’ heterochromic uveitis:  a case report[J]. Clin Ophthalmol, 2011, 5:  557-559. DOI: 10.2147/OPTH.S19525.
[17]AOKI S, INOUE T, KUSAKABE M, et al. Unilateral pigmented paravenous retinochoroidal atrophy with retinitis pigmentosa in the contralateral eye:  A case report[J]. Am J Ophthalmol Case Rep, 2017, 8:  14-17. DOI: 10.1016/j.ajoc.2017.08.003.
[18]POTSIDIS E, BERSON E L, SANDBERG M A. Disease course of patients with unilateral pigmentary retinopathy[J]. Invest Ophthalmol Vis Sci, 2011, 52(12):  9244-9249. DOI: 10.1167/iovs.11-7892.
[19]WELLER J M, MICHELSON G, JUENEMANN A G. Unilateral retinitis pigmentosa:  30 years follow-up[J]. BMJ Case Rep, 2014, 2014:  bcr2013202236. DOI: 10.1136/bcr-2013-202236.
[20]MIZOBUCHI K, KATAGIRI S, HAYASHI T, et al. Clinical findings of end-stage retinitis pigmentosa with a homozygous PDE6A variant (p.R653X)[J]. Am J Ophthalmol Case Rep, 2019, 13:  110-115. DOI: 10.1016/j.ajoc.2018.12.019.
[21]GAUVIN M, CHAKOR H, KOENEKOOP R K, et al. Erratum to:  Witnessing the first sign of retinitis pigmentosa onset in the allegedly normal eye of a case of unilateral RP:  a 30-year follow-up[J]. Doc Ophthalmol, 2016, 132(3):  231. DOI: 10.1007/s10633-016-9542-1.
[22]STROUGO Z, BADOUX A, DUCHANEL D. Psycho-affective problems associated with retinitis pigmentosa[J]. J Fr Ophtalmol, 1997, 20(2):  111-116.
 

更新日期/Last Update: 2019-10-25